Health
COVID-19 vaccine developed by German research group fails in early trial – TheChronicleHerald.ca
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for…
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for immune reaction in early-stage testing on humans, trial organisers at university hospital Hamburg-Eppendorf (UKE) said on Friday.
Further testing has been suspended until the cause for the weak immunogenicity in the Hamburg trial involving 30 volunteers has been established, UKE said in a statement, adding that the vaccine was well…
-
Business22 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
General15 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News14 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
General16 hours agoGrieving Bunbury family outraged over plan to remove roadside memorial